Gut dysbiosis is characterized by reduced microbial diversity and shifts in bacterial composition. It is a prominent feature in Parkinson’s disease (PD), often preceding motor symptoms by years and contributing to disease initiation and progression via the microbiota-gut-brain axis. PD patients exhibit consistent alterations, including depletion of short-chain fatty acid (SCFA)-producing bacteria and enrichment of […]
Gut microbiome testing can provide insights into the composition and diversity of microorganisms in our gastrointestinal tract. This may be particularly relevant in people with Candida overgrowth, leaky gut, acid reflux (GERD), long-term PPI use (Prilosec), and a history of corticosteroids, antibiotics, and thyroid medication (Synthroid). Let us address the role of gut microbiome testing […]
Below, I’ll provide additional details on the link between gut dysbiosis, acid reflux (GERD), and asthma, focusing on recent research (2023–2025) on the gut-lung axis and practical strategies for managing GERD in the context of dysbiosis, tailored to a client’s situation (Candida overgrowth, leaky gut, long-term PPI, corticosteroid, antibiotic, and thyroid medication use). I’ve incorporated […]
Have you ever wondered if there is any link between our gut and the brain? A significant link exists between our gut and our brain, known as the gut-brain axis, in which the vagus nerve, often referred to as “the wanderer,” the longest nerve in the body, plays a critical role. The gut-brain axis refers […]
